West Pharma (WST) Tops Q3 EPS by 46c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q3 EPS of $2.66, $0.46 better than the analyst estimate of $2.20. Revenue for the quarter came in at $874.5 million versus the consensus estimate of $827.12 million.
GUIDANCE:
West Pharma sees FY2026 EPS of $9.38-$9.48, versus the consensus of $8.96. West Pharma sees FY2026 revenue of $3.41-3.42 billion, versus the consensus of $3.37 billion.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
